Your session is about to expire
← Back to Search
Other
Magnetic Mitohormesis Therapy for Frailty in Older Adults
N/A
Recruiting
Led By Pao-Feng Tsai, PhD
Research Sponsored by Auburn University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 year
Awards & highlights
Study Summary
This trial will test whether twice-weekly MMT can improve physical function in adults with limited physical ability.
Who is the study for?
This trial is for English-speaking older adults who can use a phone and have clear thinking, as shown by a Mini-Cog test. They should be physically frail or almost frail but not have had major surgery recently, changed prescriptions lately, cancer, electronic implants in their body, any condition that stops them from doing the tests and treatments of the study, or a neuro-degenerative disease.Check my eligibility
What is being tested?
The study is testing Magnetic Mitohormesis Therapy (MMT) on 30 older adults with frailty. It's set up so everyone gets real MMT for 12 weeks either at the start (Phase 1) or end (Phase 2), with fake treatment in between. The participants won't know when they're getting the real vs sham treatment.See study design
What are the potential side effects?
Since this is a pilot trial for MMT therapy which uses magnetic fields to potentially treat frailty in older adults, specific side effects are not detailed but could include discomfort or other sensations during treatment.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 1 year
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 year
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Likert scale assessment of participant satisfaction
Likert scale assessment of protocol implementation
Number of sites successfully recruited
+1 moreSecondary outcome measures
Body composition
Grip strength
Objective Frailty - Short Physical Performance Battery (SPPB)
+4 moreTrial Design
2Treatment groups
Experimental Treatment
Placebo Group
Group I: Immediate interventionExperimental Treatment1 Intervention
Magnetic Mitohormesis Therapy treatment first, then Sham treatment
Group II: Delayed interventionPlacebo Group1 Intervention
Sham treatment first, then Magnetic Mitohormesis Therapy treatment
Find a Location
Who is running the clinical trial?
Auburn UniversityLead Sponsor
72 Previous Clinical Trials
14,373 Total Patients Enrolled
QuantumTX Pte LtdNETWORK
1 Previous Clinical Trials
40 Total Patients Enrolled
Pao-Feng Tsai, PhDPrincipal InvestigatorAuburn University
2 Previous Clinical Trials
85 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I have no health conditions that prevent me from undergoing tests or treatments.I have not had major surgery in the last 6 months.I haven't changed my prescription medications significantly in the last 3 months.I have some difficulty with physical activities.I have a history of cancer.I have a history of a disease that affects the brain or nerves.
Awards:
This trial has 0 awards, including:Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Research Study Groups:
This trial has the following groups:- Group 1: Delayed intervention
- Group 2: Immediate intervention
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Are there any opportunities remaining to participate in this trial?
"As per clinicaltrials.gov, this medical research endeavour is actively recruiting participants. The trial was initially registered on April 26th 2023 and the most recent update occurred on July 3rd of the same year."
Answered by AI
What is the current enrollment cap for this research-based project?
"Affirmative. Clinicaltrials.gov states that this clinical trial is currently enrolling patients, with 30 participants needed from a single site. The study was first announced on April 26th 2023 and last edited on July 3rd of the same year."
Answered by AI
What is the ultimate aim of this investigation?
"This clinical trial's primary outcome will be quantified using a Likert scale over the course of 24 weeks. Secondary measurements include daily step count, grip strength, and research-based quality of life scores (RAND Short Form-12). The higher each score is, the better it indicates for patient outcomes."
Answered by AI
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger